Back to 
UBS Group AG
UBS Group AG
TRAX1 quarters
Position history for UBS Group AG's holdings in FIRST TRACKS BIOTHERAPEUTICS
Yes. Ubs holds 310,886 shares of TRAX (First Tracks Biotherapeutics), worth $6.3M, as of its Q2 2026 13F filing.
Current Value
$6.3M
Current Shares
310,886
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of TRAX: FMR LLC, BlackRock, Inc., STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC, Jupiter Topco LLC